CAS 1006062-28-7
:5-[4′-[[2-Butyl-4-chloro-5-[(triphenylmethoxy)methyl]-1H-imidazol-1-yl]methyl][1,1′-biphenyl]-2-yl]-2H-tetrazole
Description:
The chemical substance known as 5-[4′-[[2-Butyl-4-chloro-5-[(triphenylmethoxy)methyl]-1H-imidazol-1-yl]methyl][1,1′-biphenyl]-2-yl]-2H-tetrazole, with the CAS number 1006062-28-7, is a complex organic compound characterized by its multi-ring structure and the presence of various functional groups. It features a tetrazole ring, which is known for its stability and potential biological activity, particularly in pharmaceuticals. The compound also contains an imidazole moiety, contributing to its potential interactions in biological systems. The presence of a butyl group and a chloro substituent suggests hydrophobic characteristics, while the triphenylmethoxy group may enhance lipophilicity and influence solubility. This compound's intricate structure indicates potential applications in medicinal chemistry, possibly as a drug candidate or a biochemical probe. Its synthesis and reactivity would be of interest in the context of developing new therapeutic agents or studying its mechanism of action in biological systems. Further investigation into its properties, including solubility, stability, and biological activity, would be essential for understanding its potential applications.
Formula:C41H37ClN6O
InChI:InChI=1S/C41H37ClN6O/c1-2-3-23-38-43-39(42)37(48(38)28-30-24-26-31(27-25-30)35-21-13-14-22-36(35)40-44-46-47-45-40)29-49-41(32-15-7-4-8-16-32,33-17-9-5-10-18-33)34-19-11-6-12-20-34/h4-22,24-27H,2-3,23,28-29H2,1H3,(H,44,45,46,47)
InChI key:InChIKey=RIUQREUAFRCKLE-UHFFFAOYSA-N
SMILES:C(OCC=1N(CC2=CC=C(C=C2)C3=C(C=CC=C3)C=4NN=NN4)C(CCCC)=NC1Cl)(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7
Synonyms:- 2H-Tetrazole, 5-[4′-[[2-butyl-4-chloro-5-[(triphenylmethoxy)methyl]-1H-imidazol-1-yl]methyl][1,1′-biphenyl]-2-yl]-
- 5-[4′-[[2-Butyl-4-chloro-5-[(triphenylmethoxy)methyl]-1H-imidazol-1-yl]methyl][1,1′-biphenyl]-2-yl]-2H-tetrazole
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
5-[4′-[[2-Butyl-4-chloro-5-[(triphenylmethoxy)methyl]-1H-imidazol-1-yl]methyl][1,1′-biphenyl]-2-yl]-2H-tetrazole
CAS:Formula:C41H37ClN6OColor and Shape:SolidMolecular weight:665.2251Losartan EP Impurity I (Losartan Trityl Ether)
CAS:Formula:C41H37ClN6OColor and Shape:White To Off-White SolidMolecular weight:665.245-[4'-[[2-Butyl-4-chloro-5-[[(triphenylmethyl]oxy]methyl]-1H-imidazol-1-yl]methyl]biphenyl-2-yl]-1H-tetrazole
CAS:Formula:C41H37ClN6OColor and Shape:NeatMolecular weight:665.23Losartan Trityl Ether
CAS:<p>Impurity Losartan EP Impurity I<br>Applications Losartan Trityl Ether (Losartan EP Impurity I) is an impurity of Losartan.<br>References Duncia, J.V., et al.: J. Med. Chem., 33, 1312 (1990),<br></p>Formula:C41H37ClN6OColor and Shape:NeatMolecular weight:665.23Losartan trityl ether
CAS:<p>Losartan trityl ether is a crystalline solid that belongs to the class of benzyl compounds. It has two benzyl groups, each containing a fluorine atom and one or more substituents. Losartan trityl ether has been shown to have centrosymmetric orientations in the crystal structure. This compound also has hydrogen bonding interactions with c1-6 alkyls, such as methyl and ethyl moieties. Losartan trityl ether is most commonly used as an intermediate for the synthesis of other drugs, such as losartan potassium and losartan potassium salt.</p>Formula:C41H37ClN6OPurity:95%NmrMolecular weight:665.23 g/mol





